Optimist Retirement Group’s Gilead Sciences GILD Stock Holding History

Optimist Retirement Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,271	Closed	-$2.83M	–	122
2026 Q1	$2.83M	Sell	20,271 -841	-4%	-$118K	1.25%	14
2025 Q4	$2.59M	Buy	21,112 +1	+0%	+$122	1.19%	23
2025 Q3	$2.34M	Sell	21,111 -1,758	-8%	-$200K	1.06%	29
2025 Q2	$2.54M	Sell	22,869 -435	-2%	-$46.3K	1.22%	17
2025 Q1	$2.61M	Sell	23,304 -2,777	-11%	-$287K	1.31%	12
2024 Q4	$2.41M	Sell	26,081 -1,153	-4%	-$104K	1.14%	18
2024 Q3	$2.28M	Buy	27,234 +1,391	+5%	+$106K	1.03%	29
2024 Q2	$1.77M	Buy	25,843 +2,009	+8%	+$134K	0.93%	37
2024 Q1	$1.75M	Buy	23,834 +2,979	+14%	+$229K	0.9%	36
2023 Q4	$1.69M	Buy	+20,855	New	+$1.62M	1.1%	23

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Optimist Retirement Group's GILD Position: Q2 2026 in Review

Optimist Retirement Group sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 20,271 shares — an estimated $2.83M sold.

Optimist Retirement Group first reported a position in GILD in Q4 2023 and held it in 10 quarters. The position peaked at $2.83M in Q1 2026. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Optimist Retirement Group reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
Optimist Retirement Group sold 20,271 Gilead Sciences shares in Q2 2026, an estimated $2.83M.
Optimist Retirement Group first reported a position in Gilead Sciences in Q4 2023 and held it in 10 quarters.
Optimist Retirement Group's Gilead Sciences position peaked at $2.83M in Q1 2026.
2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Optimist Retirement Group's 13F filing for Q2 2026, filed 10 Aug 2026.